Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Vabysmo® (faricimab-svoa) – New indication
October 26, 2023 - Genentech announced the FDA approval of Vabysmo (faricimab-svoa), for the treatment of patients with macular edema following retinal vein occlusion (RVO).
